Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

24 Jan 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29367707
DOI: 10.1038/s41431-017-0081-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French studyPMID 29367707Read ↗

Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French settingSemantic proximity Read ↗

Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.Semantic proximity Read ↗

Micro-costing Diagnostics in Oncology: From Single-Gene Testing to Whole Genome SequencingSemantic proximity Read ↗

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing StudySemantic proximity Read ↗

Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness.Semantic proximity Read ↗

Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Current Status of Next-Generation Sequencing-Based Cancer Genome Profiling Tests in Japan and Prospects for Liquid BiopsySemantic proximity Read ↗

Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patientsSemantic proximity Read ↗

Assessment of Treatment Cost-effectiveness Using a Colorectal Cancer Mutation Profile.Semantic proximity Read ↗

Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.Semantic proximity Read ↗

Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancersSemantic proximity Read ↗

Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.